Efficiency of montelukast in control of atopic diseases at children of preschool age

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The aim of study. To estimate clinical efficiency of the antagonist of the leukotriiene receptors - montelukast in control of atopic diseases at children of preschool age. Materials and methods. Open randomized comparative study of clinical efficiency of montelukast in parallel groups of children of preschool age having atopic diseases was conducted. Results. Inclusion of montelukast (singular) in basic therapy of children of preschool age, having atopic diseases, allowed to decrease the number of exacerbations of a bronchial asthma and allergic rhinitis and as well as the necessity of «emergency aid», when a dose of topical glucocorticosteroids reduced 1,9 times. Conclusion. Montelukast treatment showed high clinical efficiency and allowed to control symptoms of allergic rhinitis and bronchial asthma, when it was included in the basic therapy of atopic diseases at children of preschool age.

Full Text

Restricted Access

About the authors

N A Volkova

Central Medical-Sanitary Department № 91 of the FMBA of Russia

Email: Volkov-vaa@yandex.ru
Lesnoy, Sverdlovsk region

E K Beltyukov

Ural State Medical University Ministry of Health of Russia

Ekaterinburg

References

  1. Геппе Н.А., Мокина Н.А., Малахова-Капанадзе М.А. Современные возможности применения антилейкотриеновых препаратов в терапии бронхиальной астмы у детей. Рос. Аллергол. Журн. 2007, № 3, прил. 1, с. 9.
  2. Bisgaard H., Zielen S., Garcia-Garcia M.L. et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Amer. J. Respir. Crit. Care Med. 2005, v. 171, р. 315-322.
  3. Lagos J.A., Marshall G.D. Montelukast in the management of allergic rhinitis. Ther. Clin. Risk. Manag. 2007, v. 3, р. 327-332.
  4. Phan H., Moeller M.L., Nahata M.C. Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast. Drugs. 2009, v. 69, р. 2541-2576.

Statistics

Views

Abstract: 140

Article Metrics

Metrics Loading ...

Dimensions

PlumX


Copyright © Pharmarus Print Media, 2015



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies